New hope for transplant patients: experimental drug aims to replace standard Anti-Rejection medication
Disease control
Not yet recruiting
This study is testing a new drug called VEL-101 to see if it can safely prevent the body from rejecting a new kidney after transplant. It will compare VEL-101 to the current standard medication, tacrolimus, in 120 people receiving a kidney transplant. Researchers want to see if V…
Phase: PHASE2 • Sponsor: Veloxis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC